Oncothyreon appoints new CFO
This article was originally published in Scrip
Executive Summary
The US biotechnology company Oncothyreon has appointed Julie Eastland chief financial officer and vice-president of corporate development. Ms Eastland previously served as CFO and vice-president of finance and operations at VLST, a privatelyheld biotech company, as well as finance positions at Dendreon, Amgen and Encore Media Group.